Relkryp AQ 75mg/ml Injection
Marketer
Kryptomed Formulations Pvt Ltd
Salt Composition
Diclofenac (75mg/ml)
Overview Relkryp AQ 75mg/ml Injection
Arthropan 75mg/ml Injection provides analgesic relief. Indicated for pain, inflammation, rigidity, and arthralgia associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered parenterally when oral intake is infeasible. This injection must be given by a qualified healthcare provider; self-administration is strictly prohibited. Patients with a history of cardiovascular events (e.g., heart disease, stroke) should disclose this information to their physician. Report any injection site reactions (pain, swelling, erythema) to your doctor. Common adverse effects include nausea, emesis, cephalalgia, and local injection site reactions. For extended therapy, your doctor may monitor renal and hepatic function, along with complete blood counts. Prolonged use carries a risk of serious complications, including gastrointestinal bleeding and nephropathy.
Primary Ingredients of Relkryp AQ 75mg/ml Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Relkryp AQ 75mg/ml Injection
Alleviation of discomfort
Major Benefits of Relkryp AQ 75mg/ml Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Relkryp AQ 75mg/ml Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Relkryp AQ 75mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Relkryp AQ 75mg/ml Injection works:
A single dose of Relkryp AQ 75mg/ml Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated symptoms of redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Relkryp AQ 75mg/ml Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Relkryp AQ 75mg/ml Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards, a physician might prescribe it. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administration of Relkryp AQ 75mg/ml Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Relkryp AQ 75mg/ml Injection may impair driving ability due to potential adverse reactions.
KidneyCAUTION
Relkryp AQ 75mg/ml Injection requires careful administration for individuals with impaired renal function. Dosage modification of Relkryp AQ 75mg/ml Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of Relkryp AQ 75mg/ml Injection requires careful monitoring. Dosage modification of Relkryp AQ 75mg/ml Injection might be necessary. Physician consultation is recommended.
What if you forget to take Relkryp AQ 75mg/ml Injection :
Omit a dose of Relkryp AQ 75mg/ml Injection? Seek medical advice.
Facts to Know About Relkryp AQ 75mg/ml Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently